Pablo Botella

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Prostate Cancer

Magnetic Nanoparticles

Top Venues

Nanomaterials (Basel, Switzerland)

Environmental science & technology

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Eva María Rivero-Buceta, Mirela E Encheva, Bradley Cech, Eduardo Fernandez, German Sastre, Christopher C Landry, Pablo Botella
Light-activated controlled release of camptothecin by engineering porous materials: the ship in a bottle concept in drug delivery. Nanoscale (2023)
Avelino Corma, Pablo Botella, Eva María Rivero-Buceta
Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release. Pharmaceutics 14 (1) (2022)
Micaela A Macchione, Dariana Aristizábal Bedoya, Eva Rivero-Buceta, Pablo Botella, Miriam C Strumia
Mesoporous Silica and Oligo (Ethylene Glycol) Methacrylates-Based Dual-Responsive Hybrid Nanogels. Nanomaterials (Basel, Switzerland) 12 (21) (2022)
Hyunho Kang, Wade H Elmer, Yu Shen, Nubia Zuverza-Mena, Chuanxin Ma, Pablo Botella, Jason Christopher White, Christy L Haynes
Silica Nanoparticle Dissolution Rate Controls the Suppression of Fusarium Wilt of Watermelon (Citrullus lanatus). Environmental science & technology 55 (20) (2021)
Elisa Checa-Chavarria, Eva Rivero-Buceta, Miguel Angel Sanchez Martos, Gema Martinez Navarrete, Cristina Soto-Sánchez, Pablo Botella, Eduardo Fernández
Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme. Molecular pharmaceutics 18 (4) (2021)
Carla Vidaurre-Agut, Eva María Rivero-Buceta, Christopher C Landry, Pablo Botella
Isolation and Quantification of miRNA from the Biomolecular Corona on Mesoporous Silica Nanoparticles. Nanomaterials (Basel, Switzerland) 11 (5) (2021)
Alejandro Cabrera-García, Elisa Checa-Chavarria, Jesús Pacheco-Torres, Ángela Bernabeu-Sanz, Alejandro Vidal-Moya, Eva María Rivero-Buceta, German Sastre, Eduardo Fernández, Pablo Botella
Engineered contrast agents in a single structure for T1-T2 dual magnetic resonance imaging. Nanoscale 10 (14) (2018)